voriconazole has been researched along with Eye Infections, Fungal in 280 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 58 (20.71) | 29.6817 |
| 2010's | 153 (54.64) | 24.3611 |
| 2020's | 69 (24.64) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Aragona, P; Biondo, C; Inferrera, L; Postorino, EI; Roszkowska, AM; Severo, AA | 1 |
| Prajna, NV; Radhakrishnan, N | 1 |
| Agarwal, R; Maharana, P; Saluja, G; Satpathy, G; Sharma, HP; Sharma, N; Titiyal, JS; Velpandian, T | 1 |
| Agarwal, M; Gandhi, A; Garg, A; Kumar, B; Shah, S | 1 |
| Aguilera, I; Fica, A; Godoy-Martínez, P; Montecinos-Astorga, A; Palma-Fernández, R; Pinar-Pacheco, C | 1 |
| Maher, JH; Sluch, IM | 1 |
| Nakhwa, C | 1 |
| Arunga, S; Burton, MJ; Chaudhary, P; Hoffman, JJ; Hu, VH; Leck, A; Macleod, D; Mishra, SK; Roshan, A; Sanyam, SD; Singh, SK; Yadav, R | 1 |
| Bagga, B; Kate, A; Maharana, PK; Nagpal, R; Saluja, G; Sharma, N; Singhal, D | 1 |
| Dou, Z; Li, D; Li, L; Li, S; Li, X; Liang, W; Liu, C; Wang, M; Wu, B; Zhang, X | 1 |
| Marchione, G; Midena, G; Parrozzani, R | 1 |
| Acharya, NR; Das, M; Devi, L; Krishnan, T; Lalitha, P; Lietman, TM; Liu, Z; Porco, TC; Prajna, NV; Radnakrishnan, N; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, ME | 1 |
| Karaca, U | 1 |
| Nirankari, VS; Sharma, A; Sharma, R | 1 |
| Abdalla, M; Awad, K; Awad, R; Baddour, MM; Elmassry, A; Ghaith, AA; Hafezi, F; Sheta, E; Sultan, GM | 1 |
| Li, F; Shen, Z; Zhang, Q; Zhang, Y | 1 |
| Alsarhani, W; Chew, HF; Fattouh, R; Kertes, PJ; Kus, JV; Lam, PW; Rowsell, C; Tadros, M; Tsui, GK; Yucel, Y | 1 |
| Hamor, RE; Martinez, PS; Plummer, CE; Richardson, RL; Wellehan, JFX; Whitley, RD | 1 |
| Agarwal, T; Hussain, N; Maharana, PK; Nagpal, R; Nair, S; Saluja, G; Sharma, N; Sinha, R; Titiyal, JS; Vijay, RP | 1 |
| Chan, CC; Cohen, E; Emami, S; Gould, J; Mimouni, M; Rootman, DS; Slomovic, AR; Trinh, T | 1 |
| Ayaz, Y; Erkan Pota, Ç; Koyuncu Özyurt, Ö; Ünal, M | 1 |
| Ghosh, A; Gupta, A; Gupta, P; Kaur, H; Rudramurthy, SM; Thakur, A | 1 |
| Galván Ledesma, A; Rodríguez Maqueda, M; Talego Sancha, A | 1 |
| Antoniadou, A; Argyropoulou, A; Chatziralli, I; Christofidou, M; Drogari-Apiranthitou, M; Golegou, S; Kostoula, M; Meletiadis, J; Mpakosi, A; Orfanidou, M; Papadogeorgaki, E; Petrikkos, G; Petrou, E; Platsouka, E; Siopi, M; Theodossiadis, P; Vagiakou, E; Vrioni, G | 1 |
| Agrawal, S | 1 |
| Ahmed, NH; Gupta, N; Naik, R; Sidhu, N; Tandon, R; Vanathi, M | 1 |
| Alharbi, RA; Baazeem, A; Hassan, AS; Homa, M; Kannaiyan, M; Kredics, L; Krizsán, K; Manikandan, P; Mythili, A; Othaim, A; Papp, T; Sangeetha, AB; Selvam, KP; Shobana, CS; Vágvölgyi, C | 1 |
| Chen, B; Dai, S; Gong, Y; Li, H; Liu, S; Peng, L; Zhang, H; Zhang, L | 1 |
| Abtahi, SH; Esfahanian, F; Fekri, S; Khorshidifar, M; Nouri, H; Veisi, A | 1 |
| Cho, H; Jeong, M; Yoo, S | 1 |
| Bispo, PJM; Cañete-Gibas, C; Chodosh, J; Davies, EC; Oremosu, J; Ung, L; Wiederhold, NP | 1 |
| Chang, Y; Shi, H; Wang, H; Yang, R; Zhang, M; Zhang, Y | 1 |
| Akiyama, H; Komori, A; Makimura, K; Miyakubo, T; Tamura, T; Todokoro, D | 1 |
| Anisimov, AN; Aydova, AV; Davletshina, NI; Lisovskaya, SA; Samoylov, AN | 1 |
| Chandrika, YM; Najeeb, S; Ramatchandirane, B | 1 |
| Cheng, SM; Wang, JS; Xiao, YT; Xie, HT; Zhang, MC | 1 |
| Baharani, A; Reddy P, RR; Reddy, AK | 1 |
| Cabrera-Aguas, M; Keay, L; Khoo, P; Lahra, MM; McCall, D; Watson, SL | 1 |
| Maharana, PK; Sahay, P; Singhal, D | 1 |
| Biswas, J; Kumar, A; Madhuravasal Krishnan, J; Roy, R; Singh, P | 1 |
| Dayal, A; Deshpande, M; Joshi, S; Konar, P; Mandhare, SJ; Thakur, R | 1 |
| Gibbons, A; Leung, EH; Yoo, SH | 1 |
| Krishnan, T; Lietman, TM; Narayana, S; Pickel, J; Porco, TC; Ramakrishnan, S; Redd, T; Rose-Nussbaumer, J; Samantaray, PP | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Dupont, D; Miailhes, P; Mouchel, R; Persat, F; Saison, J; Wallon, M | 1 |
| Fukuda, K; Kuroda, T; Kusano, K; Matsuda, Y; Mita, H; Nagata, S; Niwa, H; Okano, A; Tamura, N | 1 |
| Cervera-Taulet, E; Hernández-Bel, L; Hernández-Garfella, M; Mata-Moret, L; Monferrer-Adsuara, C; Ocete-Mochón, MD; Torrecillas-Muelas, M | 1 |
| Cornu, M; Fichet, C; François, N; Le, V; Leroy, J; Loridant, S; Marceau, L; Sendid, B; Vuotto, F | 1 |
| Albab, N; Belghamaidi, S; Hajji, I; Hakam, J; Moutaj, R; Moutaouakil, A; Oujidi, M | 1 |
| Afshar, AR; Ahmad, TR; Bever, GJ; Li, J; Rahman, S; Wu, F | 1 |
| Akata, F; Atalay, T; Aydin, B; Cubuk, MO; Ertop, M; Ozmen, MC; Ucgul, A | 1 |
| Kakkassery, V; Kurzai, O; von Jagow, B | 1 |
| Edwar, L; Janna, YM; Louisa, M; Rozaliyani, A | 1 |
| Agarwal, M; Kumar, SK; Rajagopal, R; S, G | 1 |
| Doan, T; Jacobs, DS; Kinde, B; Ma, KK; Ong Tone, S | 1 |
| Cheng, YYY; Cheung, NN; Gooskens, J; Houbraken, J; van Duinen, SG; Verweij, PE | 1 |
| Dai, Z; Liu, M; Qin, T; Sun, H; Xu, X; You, X; Zhang, Z; Zhu, H | 1 |
| Abd El Gawad, AEGH; El-Azeem Soliman, OA; El-Emam, GA; El-Sokkary, MMA; Girgis, GNS | 1 |
| Dubovy, SR; Palioura, S; Tsiampali, C; Yoo, SH | 1 |
| Chen, D; Tan, S; Zou, W | 1 |
| Al-Mahallawi, AM; El-Setouhy, DA; Fahmy, AM; Hassan, M; Tayel, SA | 1 |
| Aguiar, P; Conde-Penedo, A; Díaz-Tomé, V; Fernández-Ferreiro, A; García-Otero, X; González-Barcia, M; Martín-Pastor, M; Otero-Espinar, FJ; Varela-Fernández, R | 1 |
| Shahin, B; Tendo, C; Welch, J | 1 |
| Berrocal, AM; El Hamichi, S; Gold, AS; Kon Graversen, V; Murray, TG | 1 |
| Bhagali, R; Prabhudesai, MN; Prabhudesai, NP | 1 |
| Agorogiannis, EI; Arbabi, E; Kaye, SB | 1 |
| Bovone, C; Busin, M; Furiosi, L; Myerscough, J; Socea, S; Spena, R; Yu, AC | 1 |
| Abu Talib, DN; Bastion, MC; Che-Hamzah, J; Nasaruddin, RA; Yong, MH | 1 |
| Hazarika, M; Prajna, NV; Senthilkumari, S | 1 |
| Chen, L; Deng, Z; Hu, S; Lei, X; Li, G; Liu, H | 1 |
| Asari, S; Ishida, K; Mochizuki, K; Murata, K; Nishida, T; Ohkusu, K; Sunada, A; Tanaka, K | 1 |
| Andreanos, K; Brouzas, D; Chatzistefanou, K; Droutsas, K; Koutsandrea, C; Kymionis, G; Mamas, N; Petrou, P | 1 |
| Acharya, NR; Das, M; Devi, L; Krishnan, T; Lietman, TM; McLeod, SD; O'Brien, KS; Oldenburg, CE; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Srinivasan, M; Zegans, ME | 1 |
| Chakraborty, A; Deshmukh, RA; Lahiri, KK; Patole, MS; Pote, ST; Shah, SR | 1 |
| Abarca, EM; Babu, RJ; Cuming, RS; Duran, S; Hathcock, T; Lin, YJ; Ravis, W; Stewart, AJ; Wooldridge, AA | 1 |
| Gray, IN; Kohli, AA; Kolomeyer, AM; Maguire, AM; O'Brien, JM; Traband, A; Uyhazi, KE | 1 |
| Acharya, NR; Das, M; Krishnan, T; Lietman, TM; McLeod, SD; Oldenburg, CE; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Srinivasan, M; Zegans, ME | 1 |
| Agarwal, T; Maharana, PK; Satpathy, G; Sharma, N; Singhal, D; Sinha, R; Titiyal, JS; Upadhyay, AD; Velpandian, T | 1 |
| Ramírez Soto, MC | 1 |
| Archana, PT; Geraldine, P; Ruban, VV; Sundararajan, M; Thomas, PA | 1 |
| Acharya, NR; Amza, A; Lietman, TM; Loh, A; Mannis, MJ; Oldenburg, CE; Prajna, NV | 1 |
| Barbhaya, RD; Dastidar, AG; Roy, R; Saurabh, K; Vyas, C | 1 |
| Frings, A; Geerling, G; Habbe, KJ; Kurzai, O; MacKenzie, C; Roth, M; Schrader, S; Walther, G | 1 |
| Chandra, A; Gupta, MK; Prakash, P; Tilak, R | 1 |
| Akiyama, H; Hirato, J; Hoshino, J; Makimura, K; Todokoro, D; Yo, A | 1 |
| Acharya, NR; Das, M; Dhakhwa, K; Krishnan, T; Lalitha, P; Lietman, TM; McLeod, SD; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Zegans, ME | 1 |
| Arguello, RA; Chevez-Barrios, P; Divatia, MK; Matoba, AY | 1 |
| Deng, Y; Huang, H; Li, S; Peng, L; Wang, B; Yang, R; Yuan, J; Zhang, H; Zhong, J | 1 |
| Han, L; He, S; Li, X; Liu, X; Lui, Q; Ma, Q; Sun, S; Wang, L; Zhang, H; Zhang, J | 1 |
| Abdellaoui, T; Ajhoun, Y; Benjelloun, N; Elasri, F; Lmimouni, B; Omari, A; Oubaaz, A; Reda, K; Zerrouk, R | 1 |
| Albrieux, M; Borry, L; Garcia-Hermoso, D; Hoarau, G; Martin-Phipps, T; Peytral, J; Picot, S; Zitte-Zehler, K | 1 |
| Acharya, NR; Glymour, MM; Krishnan, T; Lietman, TM; O'Brien, KS; Oldenburg, CE; Porco, TC; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M; Venkatesh Prajna, N | 1 |
| Cho, J; Krishnan, T; Lalitha, P; Lietman, TM; Lin, YB; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J | 1 |
| Bilgihan, K; Erdoğan, M; Göçün, PU; Kalkancı, A; Karakurt, F; Öğüt, B; Özdemir, HB | 1 |
| Darcy, K; Gunn, DJ; Tavassoli, S | 1 |
| Al-Hatmi, AMS; Boral, H; de Hoog, GS; Erdem, E; Ilkit, M; Meis, JF; van Diepeningen, A; Yağmur, M | 1 |
| Chaurasia, S; Joseph, J; Nagpal, R; Ramappa, M; Rani, PK; Shah, R; Tyagi, M | 1 |
| Fujita, H; Fukushima, S; Kobayashi, T; Matsumoto, T; Miyazaki, Y; Nakamura, I; Shimoinaba, M; Watanabe, Y | 1 |
| Berrospi, R; Galvis, V; Ramírez, D; Tello, A; Villarreal, D | 1 |
| Bansal, R; Dhingra, D; Dogra, M; Sharma, SP | 1 |
| Chang, YH; Chang, YM; Chen, YJ; Chien, KH; Liang, CM; Nieh, S; Tai, MC | 1 |
| Kasetsuwan, N; Pisuchpen, P; Reinprayoon, U; Sawanwattanakul, S; Taechajongjintana, M | 1 |
| Bilgihan, K; Erdoğan, M; Hizel, K; Kalkanci, A; Karakus, AK; Ozdemir, HB; Seker, T; Tum, AE; Unal, EA; Yesilirmak, N | 1 |
| Asif, MI; Maharana, PK; Sahay, P; Titiyal, JS | 1 |
| Agarwal, T; Bandivadekar, P; Chako, J; Maharana, PK; Sahay, P; Saluja, G; Satpathy, G; Sharma, N; Singhal, D; Sinha, R; Titiyal, JS; Velpandian, T | 1 |
| Burkholder, BM; Chang, DS; Crowell, EL | 1 |
| Bennett, HY; Hayes, RA; O'Hagan, S | 1 |
| Grau-Diez, A; Ordenes-Cavieres, G; Retamal, J | 1 |
| Austin, A; Krishnan, T; Lietman, T; Narayana, S; Pickel, J; Porco, T; Ramakrishnan, S; Rose-Nussbaumer, J; Samantaray, PP | 1 |
| Chen, HC; Chen, SY; Chen, YT; Hsiao, CH; Lin, HC; Ma, DHK; Sun, CC; Sun, PL; Tan, HY; Yeh, LK | 1 |
| Hubschman, JP; Reed, DC; Shah, KH | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
| Krishnan, T; Rishi, P | 1 |
| Azari, AA; Ghoghawala, SY; Kanavi, MR; Lee, V; Nehls, S; Potter, HD | 1 |
| Burgos Teruel, A; Domínguez-Márquez, V; Martinez-Macias, O; Navalpotro Rodríguez, D | 1 |
| Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ | 1 |
| Chodosh, J; Kohanim, S; Lo, K; Papakostas, TD; Skondra, D | 1 |
| Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T | 1 |
| Benatti, C; Cavallini, GM; Ducange, P; Volante, V | 1 |
| Açıkgöz, ZC; Cağıl, N; Can, ME; Celikbilek, N; Dereli Can, G; Kalkan Akçay, E | 1 |
| Bašková, L; Buchta, V; Feuermannová, A; Kubátová, A; Kutová, R; Váša, M; Vejsová, M | 1 |
| Gilmour, MA; Pucket, JD; Smith, KM | 1 |
| Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ | 1 |
| Binder, PS; Kontadakis, GA; Kymionis, GD; Pallikaris, IG; Plaka, AD; Tsoulnaras, KI | 1 |
| Ahmad, S; Alkharashi, M; Jun, AS | 1 |
| Gilmour, MA; Gull, T; Maxwell, L; Payton, ME; Smith, KM | 1 |
| Choi, KS; Han, SJ; Kim, ED; Rim, TH; Seo, KY; Yoon, SC | 1 |
| Acharya, NR; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Oldenburg, CE; Prajna, NV; Ray, KJ; Sun, CQ | 1 |
| Eguchi, H; Hayashi, Y; Mitamura, Y; Toibana, T; Yaguchi, T | 1 |
| Fukuchi, M; Kishi, S; Todokoro, D; Yamada, N | 1 |
| Hou, J; Tu, EY | 1 |
| Adrados Calleja, R; Caceda Castañeda, BM; Cisterna Cancer, R; Unzaga Barañano, MJ | 1 |
| Choong, K; Hirst, LW; Playford, EG | 1 |
| Jain, R; Mittal, R; Mittal, V; Sangwan, VS | 1 |
| Kalaiselvi, G; Krishnan, T; Narayana, S; Sengupta, S | 1 |
| Flynn, HW; Miller, D; Silva, RA; Sridhar, J; Wykoff, CC | 1 |
| Lekhanont, K; Nimvorapun, N; Nonpassopon, M; Santanirand, P | 1 |
| Amescua, G; Quintero-Estades, JA; Valenzuela, F; Walter, S | 1 |
| Ali, MH; Das, S; Fernandes, M; Garg, P; Kumar Koday, N; Motukupally, SR; Sahu, SK; Sharma, S; Virdi, A | 1 |
| Acharya, NR; Keenan, JD; Krishnan, KT; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M | 1 |
| Dugar, J; Miller, D; OʼBrien, TP; Spierer, O | 1 |
| Das, MR; Keenan, JD; Mascarenhas, J; Prajna, L; Prajna, VN; Radhakrishnan, N; Uddaraju, M | 1 |
| Evans, JR; FlorCruz, NV | 1 |
| Acharya, N; Lietman, TM; O'Brien, KS; Prajna, L; Prajna, NV; Rose-Nussbaumer, J; Sun, CQ | 1 |
| Holland, L; Lee, GA | 1 |
| Cheng, SC; Kuo, CN; Lai, LJ; Lin, YY | 1 |
| Hurn, SD; Nevile, JC; Turner, AG | 1 |
| Conrad, D; Turner, LD | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M | 1 |
| Cheng, Y; Liu, Z; Song, X; Su, G; Wang, C; Zhao, J | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Meenakshi, R; Ramakrishnan, R; Rameshkumar, G; Rathi, H; Venugopal, A | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Raghavan, A; Rajaraman, R; Rose-Nussbaumer, J; Srinivasan, M; Zegans, M | 1 |
| Durukan, H; Gümral, R; Mutlu, AG; Mutlu, FM; Saracli, MA; Sobaci, G; Yildiran, ST | 1 |
| Bergin, C; Guber, I; Majo, F | 1 |
| Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I | 1 |
| Johnson, Z; Maudgil, A; Mudhar, HS; Rogers, N | 1 |
| Bui, DK; Carvounis, PE | 1 |
| Irkec, M; Palamar, M; Polat Hilmioglu, S; Yagci, A | 1 |
| Rathi, HS; Ravindran, M; Rengappa, R; Venugopal, A | 1 |
| He, Y; Li, J; Li, JC; Sun, ST; Tao, SY; Wang, LL; Wang, LY; Xu, ZZ; Yu, XF; Zhang, JJ; Zhang, YQ; Zhu, L | 1 |
| Acharya, NR; Das, M; Krishnan, T; Lietman, TM; McLeod, SD; O'Brien, KS; Oldenburg, CE; Patel, S; Porco, TC; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Srinivasan, M; Zegans, ME | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Dhingra, D; Hemanth, V; Jain, AK; Kaur, S; Malhotra, C; Sharma, SP | 1 |
| Dey, P; Gupta, A; Gupta, P; Gupta, V; Kaur, J; Sachdev, N | 1 |
| Graybill, JR; Hariprasad, SM; Lin, TK; Mieler, WF; Sponsel, WE | 1 |
| Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Agee, S; Ford, JG; Greenhaw, ST | 1 |
| De Kaspar, HM; Kampik, A; Kernt, M; Neubauer, AS | 1 |
| Tu, EY | 1 |
| Deng, SX; Hollander, DA; Kamal, KM | 1 |
| Kim, SD; Lee, JJ; Lee, SJ | 1 |
| Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K | 1 |
| Almony, A; Apte, RS; Kraus, CL | 1 |
| Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K | 1 |
| Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S | 1 |
| Colby, KA; Mandell, KJ | 1 |
| Constantinou, M; Jhanji, V; Sheorey, H; Vajpayee, RB; Yohendran, J | 1 |
| Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF | 1 |
| Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL | 1 |
| Hara, Y; Mitani, A; Miyamoto, H; Ohashi, Y; Shiraishi, A; Uno, T; Yamaguchi, M | 1 |
| Buil, JA; Díaz-Cascajosa, J; Roselló, N; Sanchez, F; Vela, JI | 1 |
| Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC | 1 |
| Chew, HF; Cohen, EJ; Jungkind, DL; Mah, DY; Raber, IM; Tokarczyk, MJ; Toll, AD | 1 |
| Borse, N; Jain, V; Natarajan, S; Shome, D | 1 |
| Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH | 1 |
| Gabrielian, A; Hariprasad, SM | 1 |
| Lee, HN; Shen, YC; Tsai, HY; Wang, CY | 1 |
| Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A | 1 |
| Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P | 1 |
| Grundon, RA; Hardman, C; Muhlnickel, C; O'Reilly, A; Stanley, RG | 1 |
| Gupta, P; Haripriya, A; Lalitha, P; Nirmal, J; Prajna, NV; Senthilkumari, S; Velpandian, T | 1 |
| Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S | 1 |
| Fernandes, M; Goyal, J; Shah, SG | 1 |
| Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM | 1 |
| Arora, R; Goyal, J; Gupta, D; Kaur, R | 1 |
| Chen, KJ; Hsiao, CH; Sun, CC; Tan, HY; Yeh, LK | 1 |
| Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
| Bigorra, L; Garduño, E; Hidalgo, R; Torres, JP | 1 |
| Flynn, HW; Liggett, PE; Scartozzi, R; Tom, D | 1 |
| Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N | 1 |
| Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Grossniklaus, HE; Hall, T; Khandelwal, SS; Stulting, RD; Woodward, MA | 1 |
| Funakoshi, Y; Matsuoka, H; Minami, H; Yakushijin, K | 1 |
| Kong, DC; Leung, L; Neoh, CF; Stewart, K; Vajpayee, RB | 1 |
| Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG | 1 |
| Dong, X; Min, X; Wu, X; Xie, L; Yang, L | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| Das, M; Dikshit, S; Murthy, SI; Rathi, V | 1 |
| Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
| Agarwal, P; Gogia, V; Gupta, S; Satpathy, G; Shrivastava, RM; Tandon, R | 1 |
| Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Stirbu, O; Suriano, MM; Vila Arteaga, J | 1 |
| Berbel, RF; Casella, AM; de Freitas, D; Höfling-Lima, AL | 1 |
| Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
| Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V | 1 |
| Binder, DR; Herring, IP; Sugrue, JE | 1 |
| Acharya, NR; Gronert, K; Keenan, JD; Krishnan, T; Lietman, TM; Oldenburg, CE; Prajna, NV; Ray, KJ | 1 |
| Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
| Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Mittal, R; Mittal, V | 1 |
| Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
| Allbaugh, RA; Pucket, JD; Rankin, AJ | 1 |
| Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J | 1 |
| Constantinou, M; Jhanji, V; Ramakrishnan, T; Vajpayee, RB | 1 |
| Cheng, ML; Ha, E; Leibowitz, M | 1 |
| Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C | 1 |
| Behrens-Baumann, W; Haeberle, H; Hofmüller, W; Seibold, M; Tammer, I; Tintelnot, K; Walter, S; Wecke, T | 1 |
| Bienvenu, AL; Borderie, V; Chaumeil, C; Cornet, M; Gaujoux, T; Goldschmidt, P; Grenouillet, F; Lortholary, O; Obenga, G; Pons, D; Ranque, S; Sitbon, K; Troke, P | 1 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Sy, A; Toutain-Kidd, CM; Zegans, ME | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM | 1 |
| Chang, YF; Lee, FL; Lee, SM; Yang, CS | 1 |
| Chacko, J; Satpathy, G; Sharma, N; Sinha, R; Tandon, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Hoenigl, M; Krause, R | 1 |
| Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ | 1 |
| Borowiec-Chłopek, Z; Czepita, D; Giedrys-Kalemba, S; Karczewicz, D; Kot, J; Lachowicz, E | 1 |
| Jones, DB; Shah, KB; Wilhelmus, KR; Wu, TG | 1 |
| Harris, GJ; Kim, JE; Perkins, SL | 1 |
| Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ | 1 |
| Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K | 1 |
| Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D | 1 |
| Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR | 1 |
| Gao, H; Hariprasad, SM; Holz, ER; Mieler, WF; Pennesi, ME; Qiao, X; Shah, K; Wu, SM | 1 |
| Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C | 1 |
| Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK | 1 |
| Jang, GJ; Kim, KS; Lee, WK; Shin, WS | 1 |
| McCluskey, P; Singh, RP | 1 |
| Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH | 1 |
| Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S | 1 |
| Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
| Cohen, EJ; Hammersmith, KM; Kang, S; Ozbek, Z; Rapuano, CJ; Sivalingam, J | 1 |
| Chen, N; Dang, D; Glickman, R; Graybill, J; Lam, KW; Najvar, LK; Paris, G; Scribbick, F; Sponsel, W; Zhou, L | 1 |
| Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
| Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV | 1 |
| Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D | 1 |
| Lee, GA; McDougall, R; Whitehead, K | 1 |
| Beck, R; Kaben, U; Tintelnot, K | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ | 1 |
| Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
| Ayadi, A; Ben Salah, S; Ben Zina, Z; Cheikrouhou, F; Colin, J; Feki, J; Makni, F; Mlik, M | 1 |
| Colby, K; Jurkunas, UV; Langston, DP | 1 |
| Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Fincher, T; Fulcher, SF | 1 |
| Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
| Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L | 1 |
| Park, AJ; Tu, EY | 1 |
| Blumenkranz, MS; Egbert, P; Jain, A; McCulley, TJ; Moshfeghi, DM | 1 |
| Jain, A; Sun, Y; Ta, CN | 1 |
| Guest, S; Zarkovic, A | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Mian, P; Pagani, L; Spoladore, G; Vedovelli, C | 1 |
| Jones, A; Muhtaseb, M | 1 |
| Hariprasad, SM; Lin, RC; Sanduja, N | 1 |
| Goel, M; Prakash, G; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Agostini, H; Althaus, C; Jensen, HE; Reis, A; Sundmacher, R; Tintelnot, K | 1 |
17 review(s) available for voriconazole and Eye Infections, Fungal
| Article | Year |
|---|---|
Combined Phialemonium curvatum and Acanthamoeba Keratitis: The Importance of Early Diagnosis and Specific Therapy.
Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Biguanides; Disinfectants; Drug Therapy, Combination; Early Diagnosis; Eye Infections, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Moxifloxacin; Mycoses; Ophthalmic Solutions; Slit Lamp Microscopy; Voriconazole | 2021 |
Fusarium Causing Recalcitrant Post-operative endophthalmitis-Report of a Case with Review of Literature.
Topics: Adult; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Male; Postoperative Complications; Vitrectomy; Voriconazole | 2022 |
Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes.
Topics: Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Keratitis; Natamycin; Voriconazole | 2022 |
Initial Case Report of Cladorrhinum samala Mycotic Keratitis.
Topics: Adult; Agar; Corneal Ulcer; Culture Media; Eye Infections, Fungal; Glucose; Humans; Keratitis; Male; Natamycin; Ophthalmic Solutions; Sordariales; Voriconazole | 2022 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Differences in clinical ocular outcomes between exogenous and endogenous endophthalmitis caused by
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Risk Factors; Sporothrix; Sporotrichosis; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult | 2018 |
Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Eye Infections, Fungal; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Mycoses; Postoperative Complications; Scedosporium; Scleritis; Tenon Capsule; Triamcinolone Acetonide; Voriconazole | 2018 |
Orbital apex syndrome secondary to aspergilloma masquerading as a paranasal sinus tumor: A case report and literature review.
Topics: Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Diagnostic Errors; Eye Infections, Fungal; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Ophthalmoplegia; Orbital Diseases; Paranasal Sinus Neoplasms; Syndrome; Treatment Outcome; Vision Disorders; Voriconazole | 2018 |
Natamycin versus voriconazole for fungal keratitis.
Topics: Antifungal Agents; Databases, Factual; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Randomized Controlled Trials as Topic; Voriconazole | 2018 |
Paecilomyces/Purpureocillium keratitis: A consecutive study with a case series and literature review.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Contact Lenses; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Paecilomyces; Retrospective Studies; Risk Factors; Voriconazole; Young Adult | 2020 |
Medical interventions for fungal keratitis.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Randomized Controlled Trials as Topic; Voriconazole | 2015 |
Cladosporium keratitis - a case report and literature review.
Topics: Administration, Topical; Antifungal Agents; Cladosporium; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Middle Aged; Mycoses; Slit Lamp; Visual Acuity; Voriconazole | 2015 |
Voriconazole in the treatment of fungal eye infections: a review of current literature.
Topics: Animals; Antifungal Agents; Eye Infections, Fungal; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2013 |
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Use of voriconazole in the treatment of fungal keratitis.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
32 trial(s) available for voriconazole and Eye Infections, Fungal
| Article | Year |
|---|---|
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
Topics: Adult; Antifungal Agents; Chlorhexidine; Corneal Ulcer; Eye Infections, Fungal; Fungi; Humans; Keratitis; Mycoses; Natamycin; Nepal; Treatment Outcome; Voriconazole | 2022 |
Continuous voriconazole lavage in managing moderate and severe fungal keratitis: a randomized controlled trial.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Therapeutic Irrigation; Voriconazole | 2023 |
[Experimental study of the effectiveness of terbinafine in the treatment of fungal keratitis].
Topics: Animals; Corneal Ulcer; Eye Infections, Fungal; Ophthalmology; Rabbits; Terbinafine; Voriconazole | 2023 |
The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Corneal Perforation; Corneal Stroma; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Injections, Intraocular; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Prognosis; Time Factors; Visual Acuity; Voriconazole; Young Adult | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Topics: Administration, Oral; Antifungal Agents; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity; Voriconazole | 2017 |
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
Topics: Administration, Oral; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Suppuration; Visual Acuity; Voriconazole | 2017 |
Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Ketoconazole; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Tears; Visual Acuity; Voriconazole | 2017 |
The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
Topics: Administration, Oral; Adult; Antifungal Agents; Bacteriological Techniques; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; India; Keratoplasty, Penetrating; Male; Middle Aged; Nepal; Re-Epithelialization; Risk Assessment; Treatment Outcome; Vision Disorders; Visual Acuity; Voriconazole | 2018 |
Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
Topics: Administration, Oral; Aged; Antifungal Agents; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Eye Infections, Fungal; Female; Follow-Up Studies; Fungi; Humans; Male; Middle Aged; Ophthalmic Solutions; Treatment Outcome; Visual Acuity; Voriconazole | 2018 |
Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Bacteriological Techniques; Case-Control Studies; Combined Modality Therapy; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Treatment Outcome; Visual Acuity; Voriconazole | 2018 |
Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
Topics: Adult; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Injections, Intraocular; Keratitis; Male; Middle Aged; Natamycin; Voriconazole | 2019 |
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Topics: Antifungal Agents; Bayes Theorem; Corneal Ulcer; Expert Testimony; Eye Infections, Fungal; Fusariosis; Humans; Natamycin; Pyrimidines; Surveys and Questionnaires; Triazoles; Voriconazole | 2013 |
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing | 2013 |
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2014 |
Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Topics: Administration, Topical; Antifungal Agents; Cicatrix; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Epithelium, Corneal; Eye Infections, Fungal; Fungi; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Natamycin; Ophthalmic Solutions; Re-Epithelialization; Treatment Outcome; Visual Acuity; Voriconazole | 2014 |
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Multivariate Analysis; Natamycin; Ophthalmic Solutions; Prospective Studies; Visual Acuity; Voriconazole | 2015 |
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Vision, Ocular; Visual Acuity; Voriconazole | 2015 |
Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial.
Topics: Administration, Topical; Adult; Antifungal Agents; Collagen; Combined Modality Therapy; Cornea; Corneal Perforation; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microscopy, Confocal; Middle Aged; Natamycin; Ophthalmic Solutions; Photosensitizing Agents; Riboflavin; Ultraviolet Rays; Voriconazole | 2015 |
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Double-Blind Method; Drug Resistance, Fungal; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Voriconazole | 2015 |
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
Topics: Antifungal Agents; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Treatment Outcome; Vision, Low; Visual Acuity; Voriconazole | 2016 |
Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Drug Resistance, Multiple, Fungal; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Visual Acuity; Voriconazole | 2016 |
Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Area Under Curve; Cataract Extraction; Chromatography, High Pressure Liquid; Corneal Ulcer; Drug Stability; Eye Infections, Fungal; Female; Half-Life; Humans; Male; Middle Aged; Preservatives, Pharmaceutical; Pyrimidines; Tandem Mass Spectrometry; Tissue Distribution; Triazoles; Voriconazole | 2010 |
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
Ocular manifestations of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
Gender differences in re-epithelialisation time in fungal corneal ulcers.
Topics: Antifungal Agents; Corneal Ulcer; Epithelium, Corneal; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Natamycin; Prospective Studies; Pyrimidines; Sex Characteristics; Triazoles; Voriconazole; Wound Healing | 2012 |
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2012 |
Voriconazole for fungal corneal ulcers.
Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Predictors of outcome in fungal keratitis.
Topics: Administration, Topical; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Debridement; Double-Blind Method; Eye Infections, Fungal; Female; Humans; Male; Natamycin; Ophthalmic Solutions; Outcome and Process Assessment, Health Care; Prognosis; Prospective Studies; Pyrimidines; Re-Epithelialization; Risk Factors; Time Factors; Triazoles; Visual Acuity; Voriconazole | 2012 |
Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Corneal Stroma; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections; Keratitis; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
232 other study(ies) available for voriconazole and Eye Infections, Fungal
| Article | Year |
|---|---|
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Intrastromal natamycin: A well-aimed arrow in a difficult battle.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Natamycin; Voriconazole | 2021 |
Determination of surgical outcomes with a novel formulation of intrastromal natamycin in recalcitrant fungal keratitis: A pilot study.
Topics: Adult; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Middle Aged; Natamycin; Pilot Projects; Prospective Studies; Treatment Outcome; Voriconazole | 2021 |
[Invasive ocular fungal infection by Scedosporium apiospermum in an immunocompromised patient].
Topics: Aged; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Scedosporium; Voriconazole | 2021 |
Ramularia Keratitis.
Topics: Antifungal Agents; Ascomycota; Cornea; Eye Infections, Fungal; Humans; Keratitis, Dendritic; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Treatment Outcome; Visual Acuity; Voriconazole | 2022 |
Endogenous fungal endopthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: A case report.
Topics: Antifungal Agents; Caspofungin; COVID-19; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; SARS-CoV-2; Voriconazole | 2021 |
Continuous administration of voriconazole enhances therapeutic effect for recalcitrant fungal keratitis.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Ulcer; Voriconazole | 2022 |
Endogenous Trichosporon Asahii Retinitis.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Blast Crisis; Caspofungin; Cerebrospinal Fluid; Child; Drug Therapy, Combination; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Leukemia, Myeloid, Acute; Retinitis; Trichosporonosis; Voriconazole | 2022 |
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; India; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Randomized Controlled Trials as Topic; Voriconazole | 2022 |
Scedosporium apiospermium keratitis: a case report.
Topics: Adult; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Scedosporium; Voriconazole | 2022 |
Voriconazole-impregnated multilayered AMT and intracorneal plus intracameral injection in recalcitrant fungal corneal ulcer.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Voriconazole | 2022 |
Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits.
Topics: Animals; Collagen; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Fungal; Keratitis; Photosensitizing Agents; Rabbits; Riboflavin; Ultraviolet Rays; Voriconazole | 2022 |
Case Report: A Rare Fungal Keratitis Caused by
Topics: Antifungal Agents; Ascomycota; Corneal Diseases; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Retrospective Studies; Voriconazole | 2023 |
Post-traumatic Fungal Keratitis and Endophthalmitis Caused by
Topics: Aged; Antifungal Agents; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Humans; Keratitis; Keratoplasty, Penetrating; Male; Voriconazole | 2023 |
In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Horses; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2022 |
Clinical Profile and Treatment Outcomes of Patients With Acremonium Species Positive Keratitis Managed in a Tertiary Eye Care Center.
Topics: Acremonium; Adult; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Natamycin; Treatment Outcome; Voriconazole | 2022 |
Clinical and microbiological analysis of fungal keratitis in Toronto, Canada: A 20-year study.
Topics: Animals; Antifungal Agents; Candida; Cornea; Corneal Ulcer; Eye Infections, Fungal; Humans; Retrospective Studies; Voriconazole | 2022 |
Fungal keratitis caused by Scedosporium apiospermum: a case report.
Topics: Abscess; Adult; Antifungal Agents; Cornea; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Scedosporium; Vancomycin; Voriconazole | 2022 |
Topics: Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Humans; Postoperative Complications; Saccharomycetales; Voriconazole | 2023 |
Filamentous Fungal Keratitis in Greece: A 16-Year Nationwide Multicenter Survey.
Topics: Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Greece; Humans; Keratitis; Male; Middle Aged; Prospective Studies; Voriconazole | 2022 |
Spectrum of signs, symptoms, and treatment in amphotericin B-resistant
Topics: Amphotericin B; Antifungal Agents; Cataract; Endophthalmitis; Eye Infections, Fungal; Humans; Retrospective Studies; Trichosporon; Vitrectomy; Voriconazole | 2022 |
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Topics: Adult; Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Middle Aged; Natamycin; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2022 |
Molecular identification, phylogeny and antifungal susceptibilities of dematiaceous fungi isolated from human keratomycosis.
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Phylogeny; Voriconazole | 2023 |
Endogenous Fungal Endophthalmitis following COVID-19 Hospitalization: Evidence from a Year-Long Observational Study.
Topics: Adult; Amphotericin B; COVID-19; Endophthalmitis; Eye Infections, Fungal; Female; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vitrectomy; Voriconazole | 2023 |
A case of
Topics: Animals; Antifungal Agents; Candida albicans; Dog Diseases; Dogs; Eye Infections, Fungal; Keratitis; Tomography, Optical Coherence; Voriconazole | 2023 |
Fungal keratitis caused by Coniochaeta mutabilis-A case report.
Topics: Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Voriconazole | 2023 |
Bilateral endogenous fungal endophthalmitis: A case report.
Topics: Adult; Antifungal Agents; DNA; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Inflammation; Pregnancy; Vitrectomy; Voriconazole | 2023 |
Fungal Keratitis Caused by Talaromyces coalescens: A Case Report.
Topics: Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Natamycin; Talaromyces; Voriconazole | 2023 |
Successful Management of Fungal Keratitis Caused by Multidrug-Resistant Cladosporium Species Using Povidone-Iodine.
Topics: Antifungal Agents; Cladosporium; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Povidone-Iodine; Voriconazole | 2024 |
Botryosphaeria dothidea Mycotic Keratitis: A Novel Phytopathogen Causing Human Infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Voriconazole | 2024 |
Topics: Administration, Ophthalmic; Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Eye Infections, Fungal; Female; Humans; Itraconazole; Phacoemulsification; Scleritis; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Candida parapsilosis; Contact Lenses; Cornea; Corneal Diseases; Eye Infections, Fungal; Female; Fungi; Fusarium; Humans; Keratitis; Male; Middle Aged; Natamycin; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2020 |
Re: Narayana et al.: Mycotic antimicrobial localized injection: a randomized clinical trial evaluating intrastromal injection of voriconazole (Ophthalmology. 2019;126:1084-1089).
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Voriconazole | 2019 |
Cladosporium Endogenous Endophthalmitis Mimicking Toxoplasma Retinochoroiditis.
Topics: Adult; Antifungal Agents; Aqueous Humor; Chorioretinitis; Cladosporium; DNA, Fungal; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Mycoses; Polymerase Chain Reaction; Toxoplasmosis, Ocular; Vitreous Body; Voriconazole | 2021 |
Intrastromal voriconazole: An adjuvant approach for recalcitrant mycotic keratitis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Fungi; Humans; Injections, Intraocular; Keratitis; Male; Middle Aged; Prospective Studies; Treatment Outcome; Voriconazole | 2020 |
Cost-Effectiveness of Antifungal Supplementation of Corneal Cold Storage Media.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cornea; Cost-Benefit Analysis; Cryopreservation; Descemet Stripping Endothelial Keratoplasty; Drug Combinations; Drug Costs; Eye Infections, Fungal; Fuchs' Endothelial Dystrophy; Health Services Research; Humans; Keratoplasty, Penetrating; Male; Organ Preservation Solutions; Postoperative Complications; Voriconazole | 2020 |
Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endophthalmitis; Eye Infections, Fungal; Female; Galactose; Humans; Male; Mannans; Middle Aged; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2020 |
Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillus; Eye Infections, Fungal; Female; Horse Diseases; Horses; Male; Microbial Sensitivity Tests; Tears; Voriconazole | 2020 |
The first case of fungal endogenous endophthalmitis caused by
Topics: Adult; Antifungal Agents; Aspergillus nidulans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Vitrectomy; Voriconazole | 2021 |
Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Central Nervous System Fungal Infections; Diabetes Complications; Eye Infections, Fungal; Humans; Immunocompetence; Invasive Fungal Infections; Male; Middle Aged; Neuroaspergillosis; Orbital Diseases; Rhinitis; Voriconazole | 2020 |
Intrastromal injection of voriconazole as a therapeutic of fungal hypopyon: a case report.
Topics: Antifungal Agents; Child; Corneal Injuries; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Treatment Outcome; Voriconazole | 2020 |
COCCIDIOIDAL ENDOPHTHALMITIS: EXCELLENT RECOVERY OF VISION WITH AGGRESSIVE USE OF INTRAVITREAL ANTIFUNGALS AND VITRECTOMY.
Topics: Adult; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Vitrectomy; Voriconazole | 2022 |
Combined Intrastromal Voriconazole and Amphotericin B Treatment for Persistent Fungal Keratitis.
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Voriconazole | 2020 |
Case Report: Beyond the Blood-retina Barrier: Intravitreal Caspofungin for Fungal Endophthalmitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Blood-Retinal Barrier; Candida; Candidiasis; Caspofungin; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Rabbits; Voriconazole | 2020 |
Voriconazole Induced Ocular Surface Dysplasia - Report of Two Cases.
Topics: Aged; Antifungal Agents; Cornea; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Voriconazole | 2022 |
Dual Molecular Diagnosis of Microsporidia (Encephalitozoon hellem) Keratoconjunctivitis in an Immunocompetent Adult.
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Drug Therapy, Combination; Encephalitozoon; Eye Infections, Fungal; Female; Humans; Immunocompetence; Keratoconjunctivitis; Metagenomics; Microscopy, Confocal; Microsporidiosis; Polymerase Chain Reaction; Voriconazole | 2021 |
Contact lens-related fungal keratitis.
Topics: Amphotericin B; Antifungal Agents; Contact Lenses, Extended-Wear; Eye Infections, Fungal; Female; Humans; Keratitis; Voriconazole; Young Adult | 2020 |
Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole.
Topics: Administration, Ophthalmic; Animals; Antifungal Agents; Candida albicans; Cornea; Drug Carriers; Eye Infections, Fungal; Female; Male; Nanoparticles; Particle Size; Permeability; Rats; Rats, Sprague-Dawley; Voriconazole | 2021 |
Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
Topics: Animals; Antifungal Agents; Candida albicans; Drug Carriers; Drug Compounding; Eye; Eye Infections, Fungal; Gels; Humans; Particle Size; Surface-Active Agents; Voriconazole; Water | 2020 |
Endothelial Biopsy for the Diagnosis and Management of Culture-Negative Retrocorneal Fungal Keratitis With the Assistance of Optical Coherence Tomography Imaging.
Topics: Antifungal Agents; Corneal Ulcer; Endothelium, Corneal; Eye Infections, Fungal; Female; Humans; Image-Guided Biopsy; Injections, Intraocular; Microscopy, Confocal; Tomography, Optical Coherence; Visual Acuity; Voriconazole; Young Adult | 2021 |
Treating Fungal Keratitis with Oral Voriconazole Only: A Case Series.
Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Voriconazole | 2021 |
Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.
Topics: Antifungal Agents; Drug Carriers; Drug Delivery Systems; Eye Infections, Fungal; Humans; Micelles; Particle Size; Voriconazole | 2021 |
In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antifungal Agents; Eye Infections, Fungal; Humans; Hydrogels; Keratitis; Ophthalmic Solutions; Positron Emission Tomography Computed Tomography; Voriconazole | 2021 |
Unusual finding of two filamentous fungi in a contact lens-related keratitis.
Topics: Antifungal Agents; Contact Lenses; Eye Infections, Fungal; Female; Fungi; Fusarium; Humans; Hypocreales; Keratitis; Middle Aged; Rare Diseases; Treatment Outcome; United Kingdom; Voriconazole | 2021 |
Case Report: Endogenous Candida Endophthalmitis in Cornelia de Lange Syndrome: Atypical Stellate Neuroretinitis.
Topics: Administration, Ophthalmic; Amphotericin B; Antifungal Agents; Bacteremia; Candida albicans; Candidemia; Candidiasis; Child, Preschool; De Lange Syndrome; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Klebsiella; Klebsiella Infections; Retinitis; Voriconazole | 2021 |
Post COVID-19 opportunistic candida retinitis: A case report.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; COVID-19; Eye Infections, Fungal; Fluconazole; Humans; Intravitreal Injections; Male; Opportunistic Infections; Retinitis; SARS-CoV-2; Tomography, Optical Coherence; Visual Acuity; Voriconazole | 2021 |
Intrastromal voriconazole for refractory infectious crystalline keratopathy associated with Candida pararugosa.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Saccharomycetales; Voriconazole | 2021 |
Interface Drainage and Antimicrobial Irrigation Avoid Repeat Keratoplasty for Post-DSAEK Cold Interface Abscess.
Topics: Abscess; Aged; Antifungal Agents; Candidiasis; Corneal Ulcer; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Fungal; Female; Humans; Reoperation; Retrospective Studies; Suction; Therapeutic Irrigation; Voriconazole | 2021 |
Chronic endogenous fungal endophthalmitis: diagnostic and treatment challenges: A case report.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Middle Aged; Vitrectomy; Voriconazole | 2021 |
Drug reservoir function of voriconazole impregnated human amniotic membrane: An
Topics: Amnion; Antifungal Agents; Eye Infections, Fungal; Humans; Moxifloxacin; Pharmaceutical Preparations; Voriconazole | 2021 |
Keratomycosis Caused by a Rare Pathogen, Myrothecium verrucaria.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Hypocreales; Keratitis; Male; Middle Aged; Natamycin; Voriconazole | 2021 |
Roussoella solani causing keratomycosis, with an observed both sexual and asexual morphs.
Topics: Aged, 80 and over; Antifungal Agents; Ascomycota; Echinocandins; Eye Infections, Fungal; Farmers; Humans; Keratitis; Lipopeptides; Male; Micafungin; Voriconazole | 2017 |
Supradescemetic voriconazole injection for Candida parapsilosis keratitis.
Topics: Aged, 80 and over; Antifungal Agents; Candida parapsilosis; Eye Infections, Fungal; Humans; Injections, Intraocular; Keratitis; Male; Treatment Outcome; Voriconazole | 2018 |
Keratitis by a rare pathogen Colletotrichum gloeosporioides: A case report.
Topics: Antifungal Agents; Colletotrichum; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Voriconazole | 2017 |
Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Chromatography, High Pressure Liquid; Conjunctiva; Cornea; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Eye Infections, Fungal; Gels; Horses; Injections, Intraocular; Polyesters; Polyethylene Glycols; Sclera; Temperature; Tissue Distribution; Voriconazole | 2017 |
Management of Presumed Endogenous Fungal Endophthalmitis in a Child With Acute Lymphoblastic Leukemia.
Topics: Adolescent; Antifungal Agents; Biopsy; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Magnetic Resonance Imaging; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Visual Acuity; Vitrectomy; Voriconazole | 2017 |
Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Topics: Administration, Topical; Animals; Antifungal Agents; Catechin; Cornea; Cytokines; Eye Infections, Fungal; Female; Fusarium; Inflammation; Keratitis; Male; Oxidative Stress; Rabbits; Voriconazole | 2018 |
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
Topics: Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Fusariosis; Health Care Surveys; Humans; Natamycin; Practice Patterns, Physicians'; Surveys and Questionnaires; Voriconazole | 2017 |
Intracorneal haemorrhage after intravitreal injections.
Topics: Aged, 80 and over; Antifungal Agents; Cornea; Corneal Diseases; Endophthalmitis; Eye Hemorrhage; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Slit Lamp Microscopy; Visual Acuity; Voriconazole | 2018 |
[Tintelnotia destructans: new enemy at the gates].
Topics: Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Voriconazole | 2018 |
Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Topics: Antifungal Agents; Aspergillus; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Humans; India; Itraconazole; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2018 |
Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Gentamicins; Humans; Keratitis; Male; Middle Aged; Moxifloxacin; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cornea; Disease Models, Animal; Drug Combinations; Drug Synergism; Epithelial Cells; Eye Infections, Fungal; Female; Gene Expression Regulation; Interferons; Interleukins; Keratitis; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Severity of Illness Index; Tacrolimus; Voriconazole; Zymosan | 2018 |
Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Ophthalmic Solutions; Peptide Elongation Factor 1; Sequence Analysis, DNA; Treatment Outcome; Voriconazole; Young Adult; Zea mays | 2018 |
[Endophthalmitis secondary to keratomycosis of unusual etiology: Scytalidium hyalinum].
Topics: Administration, Oral; Ascomycota; Ceftazidime; Diabetes Mellitus, Type 2; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Middle Aged; Mitosporic Fungi; Vancomycin; Voriconazole | 2018 |
[Fungal keratitis: A 5-year monocentric retrospective study on Reunion Island].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Corneal Injuries; Eye Infections, Fungal; Female; Fusariosis; Hospitals, University; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Reunion; Voriconazole; Wound Infection | 2018 |
Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Topics: Animals; Antifungal Agents; Candida albicans; Collagen; Cornea; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Fungal; Keratitis; Photochemotherapy; Photosensitizing Agents; Rabbits; Riboflavin; Ultraviolet Rays; Voriconazole | 2019 |
Treatment of Metarhizium fungal keratitis in the United Kingdom.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Metarhizium; Treatment Outcome; United Kingdom; Voriconazole; Young Adult | 2018 |
Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Female; Fungal Proteins; Fusariosis; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Peptide Elongation Factor 1; Sequence Analysis, DNA; Treatment Outcome; Turkey; Voriconazole | 2018 |
Management of
Topics: Administration, Oral; Adult; Antifungal Agents; Candida glabrata; Candidiasis; Cornea; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Glucocorticoids; Humans; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Prednisolone; Surgical Wound Infection; Voriconazole | 2018 |
A Case of Conjunctival Ulcer and Uveitis Caused by Acrophialophora Sp. in an Immunocompromised Patient: a Case Report and Riterature Review.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Child; Child, Preschool; Cluster Analysis; Conjunctival Diseases; DNA, Fungal; DNA, Ribosomal Spacer; Eye Infections, Fungal; Female; Humans; Immunocompromised Host; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; RNA, Ribosomal; Sequence Analysis, DNA; Treatment Outcome; Ulcer; Uveitis; Voriconazole | 2018 |
Mycotic keratitis caused by Scedosporium apiospermum in an immunocompetent patient.
Topics: Antifungal Agents; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Humans; Immunocompetence; Male; Middle Aged; Natamycin; Scedosporium; Voriconazole | 2018 |
A rare case of
Topics: Adult; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Vitreous Body; Voriconazole | 2018 |
Effectiveness of voriconazole and corneal cross-linking on Phialophora verrucosa keratitis: a case report.
Topics: Antifungal Agents; Corneal Diseases; Corneal Injuries; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Phialophora; Voriconazole | 2018 |
Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Collagen; Cornea; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Iontophoresis; Keratitis; Photochemotherapy; Rabbits; Ultraviolet Rays; Voriconazole | 2018 |
Periocular contact dermatitis with use of topical voriconazole 1% in mycotic keratitis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillus flavus; Corneal Ulcer; Dermatitis, Contact; Eye Infections, Fungal; Humans; Ketoconazole; Ophthalmic Solutions; Voriconazole | 2018 |
Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antifungal Agents; Child; Child, Preschool; Eye Infections, Fungal; Female; Humans; Infant; Injections, Intraocular; Keratitis; Ketoconazole; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Prospective Studies; Visual Acuity; Voriconazole; Young Adult | 2019 |
Central Scotoma After Liver Transplant.
Topics: Antifungal Agents; Aspergillosis; Choroiditis; Eye Infections, Fungal; Humans; Liver Transplantation; Male; Middle Aged; Scotoma; Vitreous Body; Voriconazole | 2019 |
First two cases of Exserohilum rostratum keratitis in Australia.
Topics: Adult; Antifungal Agents; Ascomycota; Australia; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Natamycin; Voriconazole | 2019 |
Resolution of Coccidioides immitis endophthalmitis with an aggressive surgical and medical therapeutic approach.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2013 |
Management of a case of Candida endogenous endophthalmitis in a neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole | 2014 |
Rhizopus keratitis following corneal trauma.
Topics: Administration, Ophthalmic; Administration, Oral; Antifungal Agents; Bacteriological Techniques; Corneal Injuries; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Eye Infections, Fungal; Eye Injuries, Penetrating; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Treatment Outcome; Triazoles; Voriconazole | 2013 |
[Severe corneal infection by Colletotrichum gloeosporioides in a farmer].
Topics: Aged; Agricultural Workers' Diseases; Antifungal Agents; Colletotrichum; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Eye Infections, Fungal; Humans; Keratitis, Herpetic; Male; Pyrimidines; Triazoles; Voriconazole | 2014 |
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole | 2013 |
Medical management of Alternaria keratitis with endophthalmitis in a patient with a corneal graft.
Topics: Administration, Oral; Administration, Topical; Adult; Alternaria; Alternariosis; Antifungal Agents; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Glucocorticoids; Humans; Male; Prednisolone; Voriconazole | 2014 |
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2014 |
Successful treatment of Fusarium keratitis after photo refractive keratectomy.
Topics: Adult; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2013 |
[Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
Topics: Antifungal Agents; Conjunctiva; Cornea; Disease Progression; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Eye Injuries; Female; Humans; Keratitis; Keratoplasty, Penetrating; Middle Aged; Natamycin; Pyrimidines; Scedosporium; Treatment Refusal; Triazoles; Turkey; Voriconazole | 2013 |
Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cataract Extraction; Disease Outbreaks; Endophthalmitis; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2014 |
Treatment of six cases of equine corneal stromal abscessation with intracorneal injection of 5% voriconazole solution.
Topics: Abscess; Animals; Antifungal Agents; Corneal Diseases; Corneal Stroma; Eye Infections, Fungal; Female; Horse Diseases; Horses; Injections, Intraocular; Male; Retrospective Studies; Voriconazole | 2014 |
Femtosecond Laser-Assisted Intra-Corneal Drug Delivery.
Topics: Abscess; Aged; Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Surgery, Laser; Corneal Ulcer; Drug Delivery Systems; Drug Implants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Lasers, Excimer; Moxifloxacin; Voriconazole | 2015 |
Utilizing hardware culture in a case of atypical keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Fungal; Humans; Male; Mycological Typing Techniques; Natamycin; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Stability of 1% voriconazole solution in a constant-rate infusion pump for topical ocular delivery to horses.
Topics: Animals; Antifungal Agents; Drug Stability; Drug Storage; Eye Infections, Fungal; Horse Diseases; Horses; Infusion Pumps; Voriconazole | 2014 |
Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.
Topics: Animals; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Rabbits; Treatment Outcome; Ultraviolet Therapy; Voriconazole | 2014 |
Polymicrobial sclerokeratitis caused by Scedosporium apiospermum and Aspergillus cibarius.
Topics: Aged; Antifungal Agents; Aspergillus; Caspofungin; Coinfection; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Keratitis; Lipopeptides; Scedosporium; Scleritis; Voriconazole | 2014 |
Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers.
Topics: Adult; Antifungal Agents; Contact Lenses, Hydrophilic; Cornea; Equipment Contamination; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Treatment Outcome; Voriconazole | 2014 |
Intrastromal antifungal injection with secondary lamellar interface infusion for late-onset infectious keratitis after DSAEK.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corneal Stroma; Corneal Ulcer; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Fungal; Fluconazole; Humans; Infusions, Intralesional; Injections, Intraocular; Male; Microscopy, Confocal; Voriconazole | 2014 |
[Post-operative endophthalmitis due to Candida parapsilosis].
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Antihypertensive Agents; Candidiasis; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Macular Edema; Recurrence; Surgical Wound Infection; Vitrectomy; Voriconazole | 2015 |
Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Keratitis; Male; Middle Aged; Mycoses; Paecilomyces; Retrospective Studies; Scleritis; Voriconazole; Young Adult | 2014 |
Post-laser in situ keratomileusis interface fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Postoperative Complications; Retrospective Studies; Surgical Flaps; Voriconazole; Young Adult | 2014 |
Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Female; Follow-Up Studies; Fungi; Humans; Injections, Intraocular; Male; Middle Aged; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult | 2015 |
Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
Topics: Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.
Topics: Aged, 80 and over; Anterior Chamber; Antifungal Agents; Corneal Stroma; Eye Infections, Fungal; Female; Humans; Injections; Keratitis; Male; Middle Aged; Mycoses; Voriconazole | 2015 |
Delayed-onset postoperative endophthalmitis secondary to Exophiala.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Endophthalmitis; Exophiala; Eye Infections, Fungal; Female; Humans; Phaeohyphomycosis; Postoperative Complications; Vitrectomy; Voriconazole | 2015 |
Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2015 |
Medical management of suspected Paecilomyces sp. deep keratitis.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Australia; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Treatment Outcome; Voriconazole | 2015 |
Keratomycosis in five dogs.
Topics: Animals; Antifungal Agents; Australia; Dog Diseases; Dogs; Eye Infections, Fungal; Keratitis; Voriconazole | 2016 |
Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia.
Topics: Adult; Aged; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Female; Host-Pathogen Interactions; Humans; Immune Tolerance; Immunocompromised Host; Male; Middle Aged; Mycoses; Paecilomyces; Queensland; Retrospective Studies; Treatment Outcome; Visual Acuity; Voriconazole; Young Adult | 2015 |
A Comparative Treatment Study of Intravitreal Voriconazole and Liposomal Amphotericin B in an Aspergillus fumigatus Endophthalmitis Model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Guinea Pigs; Intravitreal Injections; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Fungal Keratitis Caused by Exserohilum, An Emerging Pathogen.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; Communicable Diseases, Emerging; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity; Voriconazole; Young Adult | 2016 |
The first case of fungal endophthalmitis caused by Emericella nidulans after cataract surgery.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Cataract Extraction; Emericella; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Middle Aged; Postoperative Complications; Voriconazole | 2016 |
Repeated Intrastromal Injections of Voriconazole in Combination with Corneal Debridement for Recalcitrant Fungal Keratitis - a Case Series.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Cornea; Debridement; Drug Administration Schedule; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Male; Middle Aged; Treatment Outcome; Voriconazole | 2016 |
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole | 2017 |
Unusual ocular presentations of ocular phaeohyphomycosis.
Topics: Adult; Antifungal Agents; Child; Conjunctival Diseases; Corneal Ulcer; Cysts; Diagnosis, Differential; Eye Foreign Bodies; Eye Infections, Fungal; Female; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Phaeohyphomycosis; Voriconazole | 2016 |
Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Phyllachorales; Retrospective Studies; Scedosporium; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Cross-Linking Treatment and Corneal Transplant in Refractory Acremonium Keratitis: Case Report.
Topics: Acremonium; Adult; Antifungal Agents; Collagen; Corneal Transplantation; Cross-Linking Reagents; Eye Infections, Fungal; Female; Humans; Keratitis; Photosensitizing Agents; Recovery of Function; Riboflavin; Treatment Outcome; Ultraviolet Therapy; Vision, Ocular; Voriconazole | 2016 |
Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.
Topics: Adult; Aged; Antifungal Agents; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Hospitals, Special; Humans; India; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Ophthalmology; Prognosis; Retrospective Studies; Scedosporium; Tertiary Care Centers; Visual Acuity; Voriconazole; Young Adult | 2016 |
[Topical voriconazole as an effective treatment for fungal keratitis].
Topics: Administration, Topical; Adult; Alternariosis; Antifungal Agents; Aspergillosis; China; Eye Infections, Fungal; Female; Fusariosis; Humans; Keratitis; Male; Treatment Outcome; Voriconazole | 2016 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
In vivo confocal microscopic characteristics of microsporidial keratoconjunctivitis in immunocompetent adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Immunocompetence; Keratoconjunctivitis; Male; Microscopy, Confocal; Microsporidia; Microsporidiosis; Moxifloxacin; Risk Factors; Voriconazole; Young Adult | 2017 |
Endogenous mycotic endophthalmitis in an immunocompetent patient.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Fluorescein Angiography; Fundus Oculi; Humans; Immunocompetence; Injections; Male; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Vitrectomy; Vitreous Body; Voriconazole; Zygomycosis | 2009 |
[Use of topical voriconazole in Alternaria keratitis].
Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Middle Aged; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
Topics: Adult; Aged; Antifungal Agents; Cell Proliferation; Cells, Cultured; Colorimetry; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Middle Aged; Oxidative Stress; Pyrimidines; Retinal Pigment Epithelium; Treatment Outcome; Triazoles; Vitreous Body; Voriconazole | 2009 |
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole | 2009 |
The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis.
Topics: Antifungal Agents; Combined Modality Therapy; Drug Administration Routes; Endophthalmitis; Eye Infections, Fungal; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2009 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Cornea; Diagnosis, Differential; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2009 |
Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Topics: Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Eye Infections, Fungal; Female; Humans; Keratitis; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Recurrence; Salvage Therapy; Scedosporium; Triazoles; Visual Acuity; Voriconazole | 2009 |
Successful treatment of choroidal blastomycosis with oral administration of voriconazole.
Topics: Administration, Oral; Antifungal Agents; Blastomycosis; Choroid Diseases; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole | 2009 |
Keratitis resulting from Thielavia subthermophila Mouchacca.
Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole | 2009 |
Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Ascomycota; Cataract; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Eye Injuries, Penetrating; Gardening; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Plant Diseases; Postoperative Care; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2009 |
Scedosporium scleritis or keratitis or both: case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Keratitis; Keratoplasty, Penetrating; Male; Medical Records; Ophthalmic Solutions; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2009 |
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole | 2009 |
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2010 |
In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
Topics: Aged, 80 and over; Antifungal Agents; Colletotrichum; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Natamycin; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Management of endogenous cryptococcal endophthalmitis with voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2010 |
Post-traumatic fungal keratitis caused by Carpoligna sp.
Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Corneal Injuries; Corneal Ulcer; DNA, Fungal; Eye Infections, Fungal; Eye Injuries; Humans; Lacerations; Male; Mitosporic Fungi; Molecular Sequence Data; Natamycin; Polymerase Chain Reaction; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 28S; Triazoles; Voriconazole | 2010 |
Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole.
Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2010 |
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Adult; Aged; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Injections; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
Fusarium keratitis 3 weeks after healed corneal cross-linking.
Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult | 2010 |
Keratomycosis in a dog treated with topical 1% voriconazole solution.
Topics: Administration, Topical; Animals; Antifungal Agents; Dog Diseases; Dogs; Eye Infections, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2010 |
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2011 |
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Injections; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2011 |
Treatment for fungal endophthalmitis resulting from keratitis.
Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
[Fungal keratitis in an immunocompetent patient].
Topics: Adult; Antifungal Agents; Corneal Opacity; Corneal Transplantation; Corneal Ulcer; Diagnostic Errors; Drug Resistance, Fungal; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Immunocompetence; Keratitis, Herpetic; Male; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
Topics: Aged; Antifungal Agents; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Pseudophakia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2011 |
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Treatment of microsporidia keratitis with topical voriconazole monotherapy.
Topics: Administration, Topical; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microsporidia; Microsporidiosis; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fungal endophthalmitis successfully treated with intravitreal voriconazole injection.
Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Leukemia, Erythroblastic, Acute; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Fungal; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2011 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
Natamycin and voriconazole in fungal keratitis.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.
Topics: Amebiasis; Amebicides; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Eye Infections, Parasitic; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chorioretinitis; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2011 |
Curvularia lunata endophthalmitis.
Topics: Antifungal Agents; Ascomycota; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Humans; Itraconazole; Male; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2012 |
Acremonium keratomycosis in a cat.
Topics: Acremonium; Animals; Antifungal Agents; Cat Diseases; Cats; Cornea; Corneal Diseases; Eye Infections, Fungal; Female; Miconazole; Pyrimidines; Triazoles; Voriconazole | 2011 |
Intracameral and topical voriconazole for fungal corneal endoexudates.
Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Corneal Ulcer; Exudates and Transudates; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Treatment of dematiaceous fungal keratitis in a dog.
Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Dog Diseases; Dogs; Eye Infections, Fungal; Keratitis; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Failure; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2013 |
Coccidioidal endophthalmitis in immunocompetent person, California, USA.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Ultrasonography; Voriconazole | 2012 |
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole | 2012 |
Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Topics: Adult; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fungi; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2012 |
The efficacy of voriconazole in 24 ocular Fusarium infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2012 |
Voriconazole for Candida endophthalmitis.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Pyrimidines; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Urine; Voriconazole | 2012 |
[Endophthalmitis in course of candidosis--a case report].
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2012 |
Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Topics: Antifungal Agents; Cornea; Eye Infections, Fungal; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Eye Infections, Fungal; Female; Humans; Orbital Diseases; Pyrimidines; Scleral Buckling; Scleritis; Surgical Wound Infection; Triazoles; Voriconazole | 2003 |
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Use of voriconazole in candida retinitis.
Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Intravitreal voriconazole: an electroretinographic and histopathologic study.
Topics: Animals; Antifungal Agents; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Injections; Ophthalmic Solutions; Pyrimidines; Rats; Rats, Sprague-Dawley; Retina; Triazoles; Vitreous Body; Voriconazole | 2004 |
Effect of voriconazole on a corneal abscess caused by fusarium.
Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole | 2005 |
Treatment of candida chorioretinitis with voriconazole.
Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Mitomycin; Mycetoma; Naphthalenes; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Terbinafine; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2005 |
Endogenous Phialemonium curvatum endophthalmitis.
Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Voriconazole in the management of Alternaria keratitis.
Topics: Administration, Oral; Aged; Alternaria; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole | 2006 |
Topical voriconazole as a novel treatment for fungal keratitis.
Topics: Administration, Topical; Animals; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Humans; Keratitis; Paecilomyces; Pilot Projects; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2006 |
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Management of paecilomyces keratitis.
Topics: Adult; Antifungal Agents; Corneal Transplantation; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Pyrimidines; Recurrence; Sclera; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Keratomycosis due to Cylindrocarpon lichenicola].
Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
[Acanthamoeba keratitis: about the first two Tunisian cases].
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Ketoconazole; Pyrimidines; Triazoles; Tunisia; Voriconazole | 2007 |
Management of tunnel fungal infection with voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole | 2007 |
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
The fusarium keratitis outbreak: not done yet?
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2007 |
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Endogenous Scedosporium apiospermum endophthalmitis.
Topics: Adult; Antifungal Agents; Aqueous Humor; Biological Availability; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole | 2007 |
Aspergillus fumigatus keratitis following laser in situ keratomileusis.
Topics: Adult; Amputation, Surgical; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Debridement; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Pyrimidines; Surgical Flaps; Triazoles; Voriconazole | 2007 |
Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
Topics: Antifungal Agents; Child; Endophthalmitis; Eye Infections, Fungal; Eye Injuries, Penetrating; Female; Humans; Injections; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2007 |
Use of voriconazole in fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aspergillosis; Chloramphenicol; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Middle Aged; Pyrimidines; Staphylococcal Infections; Triazoles; Visual Acuity; Voriconazole | 2008 |
Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole.
Topics: Aged; Anterior Chamber; Antifungal Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Injections; Male; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2008 |
Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intralesional; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.
Topics: Adolescent; Antifungal Agents; Eye Infections, Fungal; Female; Fusarium; Humans; Pyrimidines; Triazoles; Voriconazole | 2000 |